80 related articles for article (PubMed ID: 3038549)
61. Peptidergic Systems and Cancer: Focus on Tachykinin and Calcitonin/Calcitonin Gene-Related Peptide Families.
Sánchez ML; Rodríguez FD; Coveñas R
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980580
[TBL] [Abstract][Full Text] [Related]
62. Synaptic control of motoneuronal excitability.
Rekling JC; Funk GD; Bayliss DA; Dong XW; Feldman JL
Physiol Rev; 2000 Apr; 80(2):767-852. PubMed ID: 10747207
[TBL] [Abstract][Full Text] [Related]
63. Increased expression of preprotachykinin-I and neurokinin receptors in human breast cancer cells: implications for bone marrow metastasis.
Singh D; Joshi DD; Hameed M; Qian J; Gascón P; Maloof PB; Mosenthal A; Rameshwar P
Proc Natl Acad Sci U S A; 2000 Jan; 97(1):388-93. PubMed ID: 10618428
[TBL] [Abstract][Full Text] [Related]
64. Localization of neurokinin A and chromogranin A immunoreactivity in the developing porcine adrenal medulla.
Wang JM; De Ridder EF; De Potter WP; Weyns AL
Histochem J; 1994 May; 26(5):431-6. PubMed ID: 8045783
[TBL] [Abstract][Full Text] [Related]
65. Effects of calcitonin gene-related peptide (CGRP), neurokinin A and neurokinin A (4-10) on the mitogenic response of human peripheral blood mononuclear cells.
Casini A; Geppetti P; Maggi CA; Surrenti C
Naunyn Schmiedebergs Arch Pharmacol; 1989 Mar; 339(3):354-8. PubMed ID: 2542811
[TBL] [Abstract][Full Text] [Related]
66. Isolation and characterization of substance P, substance P 5-11, and substance K from two metastatic ileal carcinoids.
Roth KA; Makk G; Beck O; Faull K; Tatemoto K; Evans CJ; Barchas JD
Regul Pept; 1985 Nov; 12(3):185-99. PubMed ID: 2417286
[TBL] [Abstract][Full Text] [Related]
67. Measurement and partial characterization of the multiple forms of neurokinin A-like immunoreactivity in carcinoid tumours.
Conlon JM; Deacon CF; Richter G; Schmidt WE; Stöckmann F; Creutzfeldt W
Regul Pept; 1986 Jan; 13(2):183-96. PubMed ID: 3006157
[TBL] [Abstract][Full Text] [Related]
68. Neuropeptide K: a major tachykinin in plasma and tumor tissues from carcinoid patients.
Theodorsson-Norheim E; Norheim I; Oberg K; Brodin E; Lundberg JM; Tatemoto K; Lindgren PG
Biochem Biophys Res Commun; 1985 Aug; 131(1):77-83. PubMed ID: 2412557
[TBL] [Abstract][Full Text] [Related]
69. Tachykinin production by carcinoid tumours in culture.
Norheim I; Wilander E; Oberg K; Theodorsson-Norheim E; Lundqvist ML; Lindgren P; Bergh J
Eur J Cancer Clin Oncol; 1987 Jun; 23(6):689-95. PubMed ID: 3477459
[TBL] [Abstract][Full Text] [Related]
70. Expression of tachykinins by ileal and lung carcinoid tumors assessed by combined in situ hybridization, immunocytochemistry, and radioimmunoassay.
Bishop AE; Hamid QA; Adams C; Bretherton-Watt D; Jones PM; Denny P; Stamp GW; Hurt RL; Grimelius L; Harmar AJ
Cancer; 1989 Mar; 63(6):1129-37. PubMed ID: 2645037
[TBL] [Abstract][Full Text] [Related]
71. Composite glandular-carcinoid tumour of the terminal ileum.
Varghese NM; Zaitoun AM; Thomas SM; Senapati A; Theodossi A
J Clin Pathol; 1994 May; 47(5):427-9. PubMed ID: 8027395
[TBL] [Abstract][Full Text] [Related]
72. Isolation and characterization of neurokinin A, neurokinin A(3-10) and neurokinin A(4-10) from a neutral water extract of a metastatic ileal carcinoid tumour.
Theodorsson-Norheim E; Jörnvall H; Andersson M; Norheim I; Oberg K; Jacobsson G
Eur J Biochem; 1987 Aug; 166(3):693-7. PubMed ID: 3038549
[TBL] [Abstract][Full Text] [Related]
73.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
74.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
75.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
76.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
77.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
78.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]